Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Memory Pharmaceuticals CFO Resigns

By Pharmaceutical Processing | December 15, 2004

MONTVALE, NJ (December 15, 2004) – Memory Pharmaceuticals Corp. announced that Dennis M. Keane, chief financial officer, has resigned effective December 24 to spend more time with his family.

Keane is expected to work with the company as a consultant through the completion of the company’s year-end 2004 audit.

Joseph M. Donabauer, controller and principal accounting officer, has been appointed to vice president, and will oversee the company’s finance functions until Keane’s successor is named.

“I want to thank Dennis for his many contributions to the company,” said Tony Scullion, chief executive officer of Memory. “I, Joe Donabauer and the rest of the finance team, wish Dennis and his family all the best in the future.”

Donabauer has more than 20 years of financial management experience. He has served as Memory’s controller since 2002 and the company’s principal accounting officer since December 2003. Prior to joining Memory, Donabauer held senior financial management positions including controller of the New Jersey operations at Genzyme Biosurgery (formerly Biomatrix Inc.). Prior to joining Genzyme, Donabauer held financial management positions at Hoffman-La Roche and Reckitt & Colman (now Reckitt Benckiser).

Memory Pharmaceuticals, a biopharmaceutical company, is focused on developing drugs for the treatment of debilitating central nervous system disorders such as Alzheimer’s disease, depression, schizophrenia, vascular dementia, mild cognitive impairment, and memory impairments associated with aging.

Related Articles Read More >

Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040
Fujifilm Diosynth Technologies
Fujifilm to spend $1.6B to bolster cell culture manufacturing services
Wyzo
Wyzo high-speed pick-and-place sidebot wins design awards
Purdue University
Purdue University launches institute for advanced manufacturing of pharmaceuticals

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards